MSM often arrives in supplement conversations with a tidy story: it contains sulfur, connective tissue uses sulfur, therefore MSM rebuilds worn joints. That leap is memorable—and too large. Knee osteoarthritis is not simply a sulfur deficiency, and a plausible biochemical story is not proof that a capsule regenerates cartilage.

A more useful question is narrower: can oral methylsulfonylmethane reduce knee pain or improve day-to-day function enough to matter? The answer from human research is cautiously “maybe.” Some controlled trials are encouraging, but they are small, use different doses and products, and do not establish cartilage repair. This guide separates those findings from the exact Canadian licence for Biogénique MSM so you can make a realistic, label-based decision.

What is MSM?

MSM stands for methylsulfonylmethane. Health Canada’s ingredient database lists dimethyl sulfone as the approved chemical name and recognizes methylsulfonylmethane and MSM as common names. It is a small sulfur-containing compound. MSM is chemically related to dimethyl sulfoxide (DMSO), but they are not interchangeable products: DMSO is commonly used topically, whereas the product discussed here is oral dimethyl sulfone.

Sulfur is part of many biological molecules, which helps explain why MSM is marketed for joints and connective tissue. That chemistry does not show that taking MSM directs sulfur into knee cartilage or reverses osteoarthritis. Clinical trials measure outcomes such as pain, stiffness and function; they do not give permission to convert “contains sulfur” into a cartilage-rebuilding promise.

What is in Biogénique MSM?

The controlled Canadian product record identifies one medicinal ingredient: dimethyl sulfone, 750 mg per capsule. The dosage form is a capsule and the Natural Product Number is 80131054. The current Biogénique product page also describes a 750 mg vegetarian capsule and references the same NPN in the introductory copy.

The controlled record currently lists non-medicinal ingredients as “N/A,” while live marketing and customer-review text make additional statements about capsule materials, fillers, vegan status and common allergens. Those are not equivalent records. People with allergies, dietary restrictions or excipient preferences should check the physical label, and the publication team should confirm the complete approved list before this article goes live.

What does the Canadian licence support?

The product-specific licensed use is precise: it helps relieve joint pain associated with osteoarthritis of the knee. That wording matters. It is not a licence to claim that this product rebuilds cartilage, prevents osteoarthritis, treats an acute knee injury, cures inflammation throughout the body or improves every painful joint.

An eight-digit NPN means Health Canada has issued a product licence for the recommended conditions of use. It does not mean every statement on a retail page, every customer testimonial or every theory about MSM has been individually proven. The most defensible consumer message stays close to NPN 80131054, the 750 mg formula and the licensed knee-osteoarthritis pain claim.

Does MSM help knee osteoarthritis pain?

Several trials report a positive signal, but the evidence is not consistent enough to promise a noticeable result. The studies also differ in dose, formulation, participant group and outcome measures. That makes “MSM worked in a study” an incomplete sentence: the next questions are which MSM, how much, for whom, for how long and by how much.

A 2011 meta-analysis of DMSO and MSM found a pooled 6.34 mm reduction on a 100 mm pain scale that was neither statistically nor clinically significant. Because that analysis combined two related but different compounds and included only one MSM trial in the quantitative pool, it cannot settle the question for this product. It does reinforce the main limitation: the evidence base is small, mixed and not strong enough for guaranteed-benefit language.

How much Biogénique MSM should you take?

For adults 19 years and older, the controlled licence directs two capsules one to three times daily, with food, and says to avoid taking the product at bedtime. Because each capsule contains 750 mg, the labelled range is:

• Two capsules once daily = 1,500 mg (1.5 g) per day.

• Two capsules twice daily = 3,000 mg (3 g) per day.

• Two capsules three times daily = 4,500 mg (4.5 g) per day.

Do not increase the dose to reproduce the 6 g/day used in the Kim pilot trial. That study dose exceeds this product’s licensed maximum. More is not automatically more effective, and a trial conducted under research supervision is not an instruction to exceed the current label.

How long does MSM take to work?

The controlled licence says to use the product for at least one month to see beneficial effects. Most of the better-known osteoarthritis trials assessed outcomes over about 12 weeks. Together, those points set a sensible expectation: MSM is not an instant rescue for a painful flare, and judging it after one or two doses is unlikely to be informative.

Before starting, choose two outcomes you can observe without special equipment—for example, pain during a usual walk and difficulty rising from a chair. Record a simple baseline, keep other major changes in mind, and reassess after the labelled trial period. If there is no meaningful improvement, the answer is not to keep escalating the dose indefinitely; review the diagnosis and plan with a health care professional.

Is MSM a replacement for knee osteoarthritis care?

No. Knee osteoarthritis care usually involves more than one tool. Education, activity adapted to ability, strengthening or supervised exercise, weight management when relevant, and appropriate medical or rehabilitation care can all matter. Medication options and injections have different benefits and risks that should be discussed with a clinician or pharmacist.

A supplement trial makes the most sense as one measured part of that plan, not as a reason to stop movement, delay assessment or discontinue prescribed treatment. MSM also does not diagnose the cause of knee pain. Tendon problems, bursitis, gout, inflammatory arthritis, infection and injury can produce symptoms that need a different response.

Safety, cautions and when to seek help

The controlled product record says some people may experience gastrointestinal discomfort or disturbances. Taking the product with food follows the licensed directions and may support tolerability. The licence also says to consult a health care practitioner before use if you are pregnant or breastfeeding, and to consult one if symptoms worsen.

Bring your full medication and supplement list to a pharmacist or clinician if you take prescription medicines, have multiple health conditions or are preparing for a procedure. Avoid assuming that a “natural” product cannot affect symptoms, adherence or clinical decisions. Stop use and seek advice if a new or persistent adverse effect appears.

A knee that becomes suddenly hot, red or very swollen; pain accompanied by fever; inability to bear weight after an injury; or rapidly worsening symptoms needs prompt assessment rather than a supplement experiment. Those features are outside the purpose of this product.

What should a credible MSM quality claim show?

Quality language works best when it names the evidence behind it. A product-specific, current certificate of analysis can document tests for a particular lot, while a supplier specification, site-level manufacturing statement and general brand testing policy answer different questions. They should not be treated as interchangeable proof.

The live product page currently makes broad statements about purity, potency, heavy metals, microbiological safety, absorption, third-party testing and batch release. The connected records reviewed for this draft did not contain a readable, product-specific finished-product COA for MSM. Until one is verified, the article should not say that the current retail lot independently passed particular limits or that absorption is superior to alternatives.

For editorial review, ask for the finished-product name, NPN, lot or batch number, test dates, methods or specifications, numerical results where appropriate, and an authorized release decision. A current document tied to the bottle is more informative than an undefined “pharmaceutical grade” or “rigorously tested” badge.

A practical decision framework

1. Confirm the target. This product is licensed for joint pain associated with osteoarthritis of the knee, not every form of joint or muscle pain.

2. Match the bottle. Look for NPN 80131054 and 750 mg of dimethyl sulfone per capsule on the current label.

3. Use the labelled range. Two capsules one to three times daily equals 1.5–4.5 g/day; take it with food and avoid bedtime.

4. Give it the labelled timeline. Assess over at least one month using a small number of real-life pain and function measures.

5. Keep the rest of the plan. Continue appropriate exercise, rehabilitation and medical care rather than treating MSM as a stand-alone fix.

6. Reassess honestly. If there is no meaningful benefit, symptoms worsen or the pattern changes, seek professional guidance instead of increasing the dose.

7. Verify the quality evidence. Confirm the complete ingredient list and ask for current lot documentation before repeating product-specific testing claims.

Frequently asked questions

What are the benefits of MSM?

For this exact product, the licensed benefit is helping relieve joint pain associated with osteoarthritis of the knee. Research suggests a possible short-term effect on pain or physical function, but the evidence is limited and does not prove cartilage rebuilding, whole-body inflammation control or universal joint benefits.

Is methylsulfonylmethane the same as DMSO?

No. They are chemically related compounds, but they are not interchangeable products. Biogénique MSM contains oral dimethyl sulfone. Evidence or safety information for topical DMSO should not be transferred to this capsule without product-specific support.

How many capsules equal 3 grams of MSM?

Each capsule contains 750 mg. Four capsules supply 3,000 mg, or 3 g. That fits within the labelled daily range, but the licence organizes dosing as two capsules one to three times daily. Follow the current label or professional advice rather than using arithmetic alone to design a regimen.

Can I take 6 grams because a study used that dose?

Not with this product under its current licensed directions. Six grams would equal eight capsules and exceeds the 4.5 g/day labelled maximum. The higher-dose pilot result does not establish that exceeding the licence is safer or more effective.

When should I take MSM?

The licence says to take it with food and avoid bedtime. It does not identify a single required meal. Choose meal-based times that fit the one-to-three-times-daily directions and support consistent use.

How soon will I notice a difference?

The label says to use it for at least one month to see beneficial effects, and several trials lasted 12 weeks. Individual results vary. MSM should not be presented as immediate pain relief.

Can MSM rebuild cartilage?

Human trials cited here primarily measured pain and function. They do not establish that oral MSM rebuilds knee cartilage or reverses osteoarthritis. “Contains sulfur” is a chemical fact, not proof of structural regeneration.

Can I take MSM with my medications?

The controlled licence does not provide a complete interaction list. Ask a pharmacist or health care practitioner to review your medicines, conditions and planned procedures, especially if your regimen is complex. Do not stop prescribed treatment to start MSM.

The bottom line

Biogénique MSM has a clear, narrow Canadian licence: 750 mg per capsule to help relieve knee-osteoarthritis joint pain, used at 1.5–4.5 g/day with food for at least one month. Small trials provide a plausible signal of benefit, but reviews find the evidence limited and the clinical importance uncertain. A fair promise is a structured, label-based trial for an appropriate adult—not cartilage repair, instant relief or a guaranteed return to pain-free movement.

Related resources

• Biogénique MSM — Current formats, price and availability.

• Quality Control — Biogénique’s quality approach and certificate information.

• Research & Innovation — How Biogénique approaches evidence and formulation.

• VitaQuiz / Find My Formula — Explore products by broader wellness goals.

References

1. Health Canada. Licensed Natural Health Products Database: product information and search. Accessed 26 August 2026. https://health-products.canada.ca/lnhpd-bdpsnh/index-eng.jsp

2. Health Canada. Natural Health Products Ingredients Database. Chemical Substance — Dimethyl sulfone. Accessed 26 August 2026. https://webprod.hc-sc.gc.ca/nhpid-bdipsn/ingredReq?id=1574

3. Biogénique. Controlled product-licence record: MSM (Methyl Sulfonyl Methane), NPN 80131054. Internal controlled file reviewed 26 August 2026.

4. Biogénique. MSM product page. Reviewed 26 August 2026. https://www.biogenique.com/products/msm

5. Kim LS, Axelrod LJ, Howard P, Buratovich N, Waters RF. Efficacy of methylsulfonylmethane (MSM) in osteoarthritis pain of the knee: a pilot clinical trial. Osteoarthritis Cartilage. 2006;14(3):286–294. doi:10.1016/j.joca.2005.10.003. https://pubmed.ncbi.nlm.nih.gov/16309928/

6. Usha PR, Naidu MUR. Randomised, double-blind, parallel, placebo-controlled study of oral glucosamine, methylsulfonylmethane and their combination in osteoarthritis. Clin Drug Investig. 2004;24(6):353–363. doi:10.2165/00044011-200424060-00005. https://pubmed.ncbi.nlm.nih.gov/17516722/

7. Debbi EM, Agar G, Fichman G, et al. Efficacy of methylsulfonylmethane supplementation on osteoarthritis of the knee: a randomized controlled study. BMC Complement Altern Med. 2011;11:50. doi:10.1186/1472-6882-11-50. https://pubmed.ncbi.nlm.nih.gov/21708034/

8. Brien S, Prescott P, Bashir N, Lewith H, Lewith G. Systematic review of the nutritional supplements dimethyl sulfoxide and methylsulfonylmethane in the treatment of osteoarthritis. Osteoarthritis Cartilage. 2008;16(11):1277–1288. doi:10.1016/j.joca.2008.03.002. https://pubmed.ncbi.nlm.nih.gov/18417375/

9. Brien S, Prescott P, Lewith G. Meta-analysis of the related nutritional supplements dimethyl sulfoxide and methylsulfonylmethane in the treatment of osteoarthritis of the knee. Evid Based Complement Alternat Med. 2011;2011:528403. doi:10.1093/ecam/nep045. https://pubmed.ncbi.nlm.nih.gov/19474240/

10. Liu X, Machado GC, Eyles JP, Ravi V, Hunter DJ. Dietary supplements for treating osteoarthritis: a systematic review and meta-analysis. Br J Sports Med. 2018;52(3):167–175. doi:10.1136/bjsports-2016-097333. https://pubmed.ncbi.nlm.nih.gov/29018060/

11. Kolasinski SL, Neogi T, Hochberg MC, et al. 2019 American College of Rheumatology/Arthritis Foundation guideline for the management of osteoarthritis of the hand, hip, and knee. Arthritis Care Res. 2020;72(2):149–162. doi:10.1002/acr.24131. https://pubmed.ncbi.nlm.nih.gov/31908149/

Disclaimer